SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-064539
Filing Date
2017-12-07
Accepted
2017-12-07 18:35:55
Documents
1
Period of Report
2017-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11443
  Complete submission text file 0001209191-17-064539.txt   14848
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
CRANDELL KEITH (Reporting) CIK: 0001219039 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245783

Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
BYBEE CLINTON (Reporting) CIK: 0001219043 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245782

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 776-380-6600
ARCH Venture Fund VIII, L.P. (Reporting) CIK: 0001605598 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245786

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 7733806600
ARCH Venture Partners VIII, LLC (Reporting) CIK: 0001616165 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245785

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 7733806600
ARCH Venture Partners VIII, L.P. (Reporting) CIK: 0001616176 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245784

Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)